PubRank

S Carillo

Author PubWeight™ 18.28‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Mouse JunD negatively regulates fibroblast growth and antagonizes transformation by ras. Cell 1994 2.00
2 Ubiquitinylation is not an absolute requirement for degradation of c-Jun protein by the 26 S proteasome. J Biol Chem 1995 1.37
3 Proteolysis by calpains: a possible contribution to degradation of p53. Mol Cell Biol 1997 1.30
4 The 'GGCC' haplotype of JAK2 confers susceptibility to JAK2 exon 12 mutation-positive polycythemia vera. Leukemia 2009 1.15
5 The efficiency of cell targeting by recombinant retroviruses depends on the nature of the receptor and the composition of the artificial cell-virus linker. J Gen Virol 1992 1.14
6 Measurement of sigma chi c2 B(chi c2-->J/psi gamma)/sigma chi c1 B(chi c1 -->J/psi gamma) in pp collisions at square root s=1.96 TeV. Phys Rev Lett 2007 1.07
7 Plasma proteasome level is a potential marker in patients with solid tumors and hemopoietic malignancies. Cancer 2001 0.99
8 Polarizations of J/psi and psi(2S) mesons produced in pp collisions at square root s = 1.96 TeV. Phys Rev Lett 2007 0.96
9 Measurement of the top-quark mass in all-hadronic decays in pp collisions at CDF II. Phys Rev Lett 2007 0.95
10 Plasma proteasome level is a reliable early marker of malignant transformation of liver cirrhosis. Gut 2009 0.90
11 High plasma proteasome levels are detected in patients with metastatic malignant melanoma. Br J Dermatol 2005 0.88
12 Search for anomalous production of multilepton events in pp collisions at sqrt s=1.96 TeV. Phys Rev Lett 2007 0.86
13 The sensitivity of c-Jun and c-Fos proteins to calpains depends on conformational determinants of the monomers and not on formation of dimers. Biochem J 2000 0.85
14 [The proteasome and malignant hemopathies]. Morphologie 2000 0.83
15 Are there multiple proteolytic pathways contributing to c-Fos, c-Jun and p53 protein degradation in vivo? Mol Biol Rep 1999 0.83
16 c-fos mRNA instability determinants present within both the coding and the 3' non coding region link the degradation of this mRNA to its translation. Oncogene 1995 0.83
17 Analysis of the quantum numbers J(PC) of the X(3872) particle. Phys Rev Lett 2007 0.83
18 Decreased susceptibility to calpains of v-FosFBR but not of v-FosFBJ or v-JunASV17 retroviral proteins compared with their cellular counterparts. Biochem J 1997 0.78
19 Measurement of sigma Lambda b0/sigma B0 x B(Lambda b0-->Lambda c+pi-)/B(B0-->D+pi-) in pp collisions at square root s=1.96 TeV. Phys Rev Lett 2007 0.75
20 Cell targeting by murine recombinant retroviruses. Bone Marrow Transplant 1992 0.75
21 Search for V+A current in top-quark decays in pp collisions at sqrts=1.96 TeV. Phys Rev Lett 2007 0.75
22 Search for chargino-neutralino production in pp collisions at sq rt[s] = 1.96 TeV. Phys Rev Lett 2007 0.75
23 First measurement of the ratio of central-electron to forward-electron W partial cross sections in pp[over] collisions at (square root)s =1.96 TeV. Phys Rev Lett 2007 0.75
24 Observation of exclusive electron-positron production in hadron-hadron collisions. Phys Rev Lett 2007 0.75
25 Measurement of the ratios of branching fractions B(B0s --> Ds- pi+ pi+ pi-)/B(B0-->D- pi+ pi+ pi-) and B(B0s --> Ds- pi+)/B(B0-->D- pi+). Phys Rev Lett 2007 0.75
26 Observation of the Heavy Baryons Sigma b and Sigma b*. Phys Rev Lett 2007 0.75
27 Observation of WZ production. Phys Rev Lett 2007 0.75
28 Inclusive search for new physics with like-sign dilepton events in pp collisions at square root of s =1.96 TeV. Phys Rev Lett 2007 0.75
29 Search for heavy long-lived particles that decay to photons at CDF II. Phys Rev Lett 2007 0.75